McBain Stuart C, Yiu Humphrey H P, Dobson Jon
Institute for Science & Technology in Medicine, Keele University, Thornburrow Drive, Harsthill, Stoke-on-Trent, UK.
Int J Nanomedicine. 2008;3(2):169-80. doi: 10.2147/ijn.s1608.
Investigations of magnetic micro- and nanoparticles for targeted drug delivery began over 30 years ago. Since that time, major progress has been made in particle design and synthesis techniques, however, very few clinical trials have taken place. Here we review advances in magnetic nanoparticle design, in vitro and animal experiments with magnetic nanoparticle-based drug and gene delivery, and clinical trials of drug targeting.
Int J Nanomedicine. 2008
Nat Nanotechnol. 2009-9
Nanomedicine (Lond). 2006-6
J Biomed Nanotechnol. 2009-8
J Nanosci Nanotechnol. 2006
Nanomedicine (Lond). 2007-4
IEEE Trans Nanobioscience. 2007-12
Nat Nanotechnol. 2009-9
Expert Rev Med Devices. 2011-5
Pharmaceuticals (Basel). 2025-7-3
Front Immunol. 2025-2-28
Int J Mol Sci. 2024-10-19
Nanomedicine (Lond). 2024
Drug Deliv. 2024-12
Soft Matter. 2006-2-15
Nanomedicine (Lond). 2006-6
Neoplasia. 2006-3
Biochim Biophys Acta. 2006-4